Book contents
- Seminars in Clinical Psychopharmacology
- College Seminars Series
- Seminars in Clinical Psychopharmacology
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Editor’s Note on Nomenclature
- Neuroscience-Based Nomenclature Glossary
- Abbreviations
- Part 1 Basic Science and General Principles
- Chapter 1 A Brief History of Psychopharmacology
- Chapter 2 Psychiatric Drug Discovery and Development
- Chapter 3 Neurotransmission and Mechanisms of Drug Action
- Chapter 4 Pharmacodynamics and Pharmacokinetics
- 4.1 Introduction
- 4.2 Key Concepts in Pharmacokinetics
- 4.3 Absorption
- 4.4 Distribution
- 4.5 Metabolism
- 4.6 Excretion
- 4.7 Half-Life and Related Issues
- 4.8 Pharmacokinetic Characteristics of Psychotropic Drugs
- 4.9 Therapeutic Drug Monitoring (TDM)
- 4.10 Introduction to Pharmacodynamics
- 4.11 Protein Targets for Drug Binding
- 4.12 Drug–Receptor Interactions
- 4.13 Drug–Receptor Affinity and Efficacy
- 4.14 Dose–Response Relationships
- 4.15 Pharmacodynamic Drug Interactions
- 4.16 Tolerance
- 4.17 Withdrawal Reactions
- 4.18 Conclusions
- Contents
- Chapter 5 Pharmacogenomics and Psychopharmacology
- Chapter 6 Good Clinical Practice in Psychopharmacology
- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups
- Part 3 Specific Therapeutic Areas
- Index
Contents
from Chapter 4 - Pharmacodynamics and Pharmacokinetics
Published online by Cambridge University Press: 29 May 2020
- Seminars in Clinical Psychopharmacology
- College Seminars Series
- Seminars in Clinical Psychopharmacology
- Copyright page
- Contents
- Contributors
- Foreword
- Preface
- Editor’s Note on Nomenclature
- Neuroscience-Based Nomenclature Glossary
- Abbreviations
- Part 1 Basic Science and General Principles
- Chapter 1 A Brief History of Psychopharmacology
- Chapter 2 Psychiatric Drug Discovery and Development
- Chapter 3 Neurotransmission and Mechanisms of Drug Action
- Chapter 4 Pharmacodynamics and Pharmacokinetics
- 4.1 Introduction
- 4.2 Key Concepts in Pharmacokinetics
- 4.3 Absorption
- 4.4 Distribution
- 4.5 Metabolism
- 4.6 Excretion
- 4.7 Half-Life and Related Issues
- 4.8 Pharmacokinetic Characteristics of Psychotropic Drugs
- 4.9 Therapeutic Drug Monitoring (TDM)
- 4.10 Introduction to Pharmacodynamics
- 4.11 Protein Targets for Drug Binding
- 4.12 Drug–Receptor Interactions
- 4.13 Drug–Receptor Affinity and Efficacy
- 4.14 Dose–Response Relationships
- 4.15 Pharmacodynamic Drug Interactions
- 4.16 Tolerance
- 4.17 Withdrawal Reactions
- 4.18 Conclusions
- Contents
- Chapter 5 Pharmacogenomics and Psychopharmacology
- Chapter 6 Good Clinical Practice in Psychopharmacology
- Part 2 Psychopharmacology of the Main Psychotropic Drug Groups
- Part 3 Specific Therapeutic Areas
- Index
- Type
- Chapter
- Information
- Seminars in Clinical Psychopharmacology , pp. 124Publisher: Cambridge University PressPrint publication year: 2020